<DOC>
	<DOC>NCT02747381</DOC>
	<brief_summary>This study evaluates the effect of vitamin D supplementation in the form of Alfacalcidol on the the pulmonary function of adult asthmatic Egyptian patients</brief_summary>
	<brief_title>The Effect of Vitamin D Supplementation on the Pulmonary Functions of Adult Asthmatic Egyptian Patients</brief_title>
	<detailed_description>Asthmatic patients are recruited and divided into two groups. One receives Alfacalcidol beside their normal medications while the other acts as a control group receiving the normal asthma medication. Both groups are followed up for four months.</detailed_description>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Hydroxycholecalciferols</mesh_term>
	<mesh_term>Alfacalcidol</mesh_term>
	<criteria>1. Patients diagnosed with asthma 2. Nonsmokers 1. Liver impairment 2. Kidney impairment 3. Patients receiving digoxin 4. Known hypersensitivity to 1Î±hydroxyvitamin D3, vitamin D or any of its analogues and derivatives 5. Hypercalcaemia 6. Hyperphosphatemia 7. Pregnancy and breastfeeding 8. Patients on nutritional supplements with a potential effect on 25(OH)D serum concentrations 9. Had a History of stones in the urinary tract or diseases of calcium or bone metabolism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>